Chengdu Bright Eye Hospital Co. Ltd.
Bright Eye Hospital Group Co., Ltd., a specialized chain medical institution company, engages in the provision of ophthalmic general medical services in China. Its ophthalmology institutions provide diagnosis, treatment, health care, medical optometry, glasses, and other general ophthalmic medical services for patients with ophthalmic diseases in the areas of refractive surgery, cataract, ophthal… Read more
Market Cap & Net Worth: Chengdu Bright Eye Hospital Co. Ltd. (301239)
Chengdu Bright Eye Hospital Co. Ltd. (SHE:301239) has a market capitalization of $731.04 Million (CN¥5.36 Billion) as of March 18, 2026. Listed on the SHE stock exchange, this China-based company holds position #12185 globally and #2989 in its home market, demonstrating a 5.75% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Chengdu Bright Eye Hospital Co. Ltd.'s stock price CN¥35.85 by its total outstanding shares 149619048 (149.62 Million).
Chengdu Bright Eye Hospital Co. Ltd. Market Cap History: 2022 to 2026
Chengdu Bright Eye Hospital Co. Ltd.'s market capitalization history from 2022 to 2026. Data shows change from $1.42 Billion to $731.04 Million (-9.61% CAGR).
Chengdu Bright Eye Hospital Co. Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Chengdu Bright Eye Hospital Co. Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.36x
Chengdu Bright Eye Hospital Co. Ltd.'s market cap is 0.36 times its annual revenue
0.38x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $1.42 Billion | $1.73 Billion | $20.57 Million | 0.82x | 69.17x |
| 2023 | $1.73 Billion | $2.72 Billion | $267.91 Million | 0.64x | 6.47x |
| 2024 | $956.37 Million | $2.68 Billion | -$101.86 Million | 0.36x | N/A |
Competitor Companies of 301239 by Market Capitalization
Companies near Chengdu Bright Eye Hospital Co. Ltd. in the global market cap rankings as of March 18, 2026.
Key companies related to Chengdu Bright Eye Hospital Co. Ltd. by market ranking:
- HCA Holdings Inc (NYSE:HCA): Ranked #271 globally with a market cap of $77.08 Billion USD.
- Tenet Healthcare Corporation (NYSE:THC): Ranked #1068 globally with a market cap of $18.32 Billion USD.
- Fresenius SE & Co. KGaA (PINK:FSNUF): Ranked #1139 globally with a market cap of $16.86 Billion USD.
- Brookdale Senior Living Inc (NYSE:BKDT): Ranked #1227 globally with a market cap of $15.19 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #271 | HCA Holdings Inc | NYSE:HCA | $77.08 Billion | $509.87 |
| #1068 | Tenet Healthcare Corporation | NYSE:THC | $18.32 Billion | $211.64 |
| #1139 | Fresenius SE & Co. KGaA | PINK:FSNUF | $16.86 Billion | $41.01 |
| #1227 | Brookdale Senior Living Inc | NYSE:BKDT | $15.19 Billion | $77.60 |
Chengdu Bright Eye Hospital Co. Ltd. Historical Marketcap From 2022 to 2026
Between 2022 and today, Chengdu Bright Eye Hospital Co. Ltd.'s market cap moved from $1.42 Billion to $ 731.04 Million, with a yearly change of -9.61%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥731.04 Million | +9.00% |
| 2025 | CN¥670.68 Million | -29.87% |
| 2024 | CN¥956.37 Million | -44.87% |
| 2023 | CN¥1.73 Billion | +21.93% |
| 2022 | CN¥1.42 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Chengdu Bright Eye Hospital Co. Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $731.04 Million USD |
| MoneyControl | $731.04 Million USD |
| MarketWatch | $731.04 Million USD |
| marketcap.company | $731.04 Million USD |
| Reuters | $731.04 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.